2nd International Congress on Pharma, Toxicology and Clinical Trials 2020
- Valencia, Spain
We take great pleasure in inviting you to the†2nd†International Congress on Pharma, Toxicology and Clinical Trials. The Conference is going to held during July 15-16, 2020 at Valencia, Spain.
The theme of the conference is Innovation and Ideas of Pharma, Toxicology and Clinical Trials
A two-day international scientific conference will be organized by Impact Conferences. Honorable speakers from around the world will share their experiences and lessons-learned in Pharma, Toxicology and Clinical Trials. This global meeting will bring together the world leaders in the expanding fields related to Pharmacologist, Scientists, Doctors, Professors, Research Fellows, Young researcher, Universities, Companies, Laboratories and Hospitals.
Delegates will be provided with the opportunity to build a global, comprehensive and diverse professional network of the other young leaders and to engage in a direct channel of interaction. Participating in this accredited platform, delegates will obtain an experience that differentiates individuals from the population of emerging graduates.
The Impact Pharma 2020 is a conference hub that covers the core topics on Pharma, Toxicology, Clinical Trials, Drug Safety, Molecular and Cellular Pharmacology, Bio markers and many more...
We cordially invite you to participate in the conference by presenting your work as either talks or posters based on the themes identified above. We hope that you will take advantage of this unique opportunity to interact with eminent scholars, researchers, practitioners and industry representatives from throughout the world whose focus is to develop new and effective drugs to improve world health.
Pharmacokinetics refers to the movement of drugs through the body. Pharmacokinetics describes a drug's exposure by characterizing absorption, distribution, bioavailability, metabolism and excretion as a function time.
Bioavailability & Bioequivalence
Bioavailability is defined as the fraction (percentage) of an administered dose of unchanged medicine that reaches the blood stream (systemic circulation).